| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-010300 |
| cik | 856984 |
| name | QHSLAB, INC. |
| sic | 3841 |
| countryba | US |
| stprba | FL |
| cityba | WEST PALM BEACH |
| zipba | 33407 |
| bas1 | 901 NORTHPOINT PARKWAY |
| bas2 | SUITE 302 |
| baph | (929) 379-6503 |
| countryma | US |
| stprma | FL |
| cityma | WEST PALM BEACH |
| zipma | 33407 |
| mas1 | 901 NORTHPOINT PARKWAY |
| mas2 | SUITE 302 |
| countryinc | US |
| stprinc | NV |
| ein | 112655906 |
| former | USA EQUITIES CORP. |
| changed | 20151119 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250514 |
| accepted | 2025-05-14 16:30:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-010300 | 20241231 | Assets | 1799552.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Accounts Payable Current | 340962.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Assets | 1667895.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Capitalized Computer Software Net | 18616.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Cash And Cash Equivalents At Carrying Value | 61065.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 15347.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -96103.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Increase Decrease In Accounts Payable | -22194.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Increase Decrease In Accounts Receivable | 58800.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Increase Decrease In Inventories | 11927.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Increase Decrease In Inventories | -12587.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Increase Decrease In Other Current Liabilities | -4300.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -417.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Interest Paid Net | 75493.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Liabilities | 2259260.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Net Income Loss | -18525.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-010300 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; | ||
| 0001641172-25-010300 | 20241231 | Preferred Stock Shares Outstanding | 2644424.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; | ||
| 0001641172-25-010300 | 20241231 | Prepaid Expense And Other Assets Current | 25791.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Repayments Of Short Term Debt | 51525.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Retained Earnings Accumulated Deficit | -4410959.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 97329.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Immunotherapy Treatment Sales; | ||
| 0001641172-25-010300 | 20241231 | Shares Outstanding | 10806527.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20231231 | Stockholders Equity | 264.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20240331 | Stockholders Equity | 108.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20241231 | Stockholders Equity | -607756.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Stockholders Equity | 264.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20241231 | Stockholders Equity | 3722141.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010300 | 20250331 | Stockholders Equity | 1128.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20211031 | Stock Issued During Period Shares Conversion Of Convertible Securities | 76923.0000 | shares | 0 | us-gaap/2024 | Debt Instrument= Eight Lakh Six Thousand Note; Legal Entity= Mercer Street Global Opportunity Fund L L C; Type Of Arrangement= Securities Purchase Agreement; | ||
| 0001641172-25-010300 | 20240331 | Stock Issued During Period Shares Conversion Of Convertible Securities | 480000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Conversion Of Convertible Securities | 37.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Issued For Services | USD | 1 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-010300 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 11191527.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Additional Paid In Capital | 3722141.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 66929.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Common Stock Shares Authorized | 900000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Convertible Notes Payable Current | 1284147.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Debt And Accrued Interest Converted To Shares Of Common Stock | 12000.0000 | USD | 1 | 0001641172-25-010300 | |||
| 0001641172-25-010300 | 20241231 | Finite Lived Intangible Assets Net | 1360109.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Interest Expense | 32129.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Interest Paid Net | 7117.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010300 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; | ||
| 0001641172-25-010300 | 20240331 | Stockholders Equity | 1022.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20250331 | Stockholders Equity | 108.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Stockholders Equity | 264.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20220731 | Stock Issued During Period Shares Conversion Of Convertible Securities | 250000.0000 | shares | 0 | us-gaap/2024 | Debt Instrument= Eight Lakh Six Thousand Note; Legal Entity= Mercer Street Global Opportunity Fund L L C; Short Term Debt Type= Convertible Notes Payable Three; Type Of Arrangement= Securities Purchase Agreement; | ||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Shares Issued For Services | 100000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 48.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20241231 | Common Stock Value | 1081.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Depreciation And Amortization | 18028.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Depreciation Depletion And Amortization | 36644.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | General And Administrative Expense | 155523.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Income Taxes Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010300 | 20240331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010300 | 20241231 | Inventory Net | 41779.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Inventory Net | 29192.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Operating Income Loss | -12039.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Provision For Doubtful Accounts | 7276.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Repayments Of Short Term Debt | 46554.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 127004.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Integrated Service Program; | ||
| 0001641172-25-010300 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 9970.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Shipping And Handling; | ||
| 0001641172-25-010300 | 20231231 | Shares Outstanding | 2644424.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20240331 | Shares Outstanding | 2644424.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Shares Outstanding | 2644424.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20231231 | Stockholders Equity | -375617.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20231231 | Stockholders Equity | -3983258.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010300 | 20241231 | Stockholders Equity | 108.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20241231 | Stockholders Equity | 1081.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20211031 | Stock Issued During Period Value Conversion Of Convertible Securities | 50000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Eight Lakh Six Thousand Note; Legal Entity= Mercer Street Global Opportunity Fund L L C; Type Of Arrangement= Securities Purchase Agreement; | ||
| 0001641172-25-010300 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Conversion Of Convertible Securities | 75000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Conversion Of Convertible Securities | 74963.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010300 | 20241231 | Accounts Receivable Net Current | 196089.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Additional Paid In Capital | 3818094.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Capitalized Computer Software Net | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010300 | 20241231 | Cash And Cash Equivalents At Carrying Value | 157168.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 51582.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 157168.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010300 | 20250331 | Earnings Per Share Diluted | -0.0100 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Gross Profit | 286158.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Gross Profit | 429944.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Increase Decrease In Accounts Receivable | 6165.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 14788.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Liabilities | 2407308.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Net Income Loss | -79609.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010300 | 20240331 | Operating Expenses | 272554.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Operating Expenses | 441983.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20210630 | Preferred Stock Par Or Stated Value Per Share | 0.2500 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-010300 | 20241231 | Preferred Stock Shares Issued | 2644424.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; | ||
| 0001641172-25-010300 | 20240331 | Provision For Doubtful Accounts | -707.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 89100.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Clinical Study Revenue; | ||
| 0001641172-25-010300 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 162502.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Integrated Service Program; | ||
| 0001641172-25-010300 | 20250331 | Selling And Marketing Expense | 144399.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20231231 | Shares Outstanding | 9735508.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20240331 | Shares Outstanding | 10215508.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20231231 | Stockholders Equity | 974.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20241231 | Stockholders Equity | -4331350.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010300 | 20250331 | Stockholders Equity | 3818094.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010300 | 20241231 | Stock Issued During Period Shares Conversion Of Convertible Securities | 125000.0000 | shares | 0 | us-gaap/2024 | Debt Instrument= Eight Lakh Six Thousand Note; | ||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Shares Conversion Of Convertible Securities | 375000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 12000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Issued For Services | 21000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Issued For Services | 20990.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010300 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 11191527.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Common Stock Shares Authorized | 900000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Accounts Payable Current | 318768.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Assets Current | 325814.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Common Stock Value | 1128.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-010300 | 20250331 | Common Stock Shares Issued | 11281527.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Common Stock Shares Outstanding | 11281527.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Cost Of Revenue | 202429.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Cost Of Revenue | 215475.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Depreciation Depletion And Amortization | 36645.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -79609.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Issuance Of Stock And Warrants For Services Or Claims | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010300 | 20241231 | Liabilities And Stockholders Equity | 1799552.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Liabilities And Stockholders Equity | 1667895.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Net Cash Provided By Used In Operating Activities | 56572.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Net Cash Provided By Used In Operating Activities | -49549.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-010300 | 20250331 | Net Income Loss | -79609.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010300 | 20241231 | Other Liabilities Current | 13536.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001641172-25-010300 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Preferred Stock Shares Outstanding | 1080092.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-010300 | 20241231 | Preferred Stock Value | 108.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-010300 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 86325.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Immunotherapy Treatment Sales; | ||
| 0001641172-25-010300 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 645419.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Shares Outstanding | 11281527.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20231231 | Stockholders Equity | 3606295.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010300 | 20240331 | Stockholders Equity | -382142.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Stockholders Equity | 3618247.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010300 | 20250331 | Stockholders Equity | -591365.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-010300 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 9877926.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 61065.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Common Stock Shares Outstanding | 10806527.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Convertible Notes Payable Current | 1209147.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Increase Decrease In Other Current Liabilities | 24077.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Issuance Of Stock And Warrants For Services Or Claims | 21000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-010300 | 20240331 | Net Income Loss | -18525.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010300 | 20241231 | Other Liabilities Current | 343945.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Other Liabilities Current | 339645.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Other Liabilities Current | 13536.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001641172-25-010300 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Preferred Stock Shares Issued | 1080092.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Preferred Stock Value | 264.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; | ||
| 0001641172-25-010300 | 20240331 | Proceeds From Related Party Debt | 10300.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Retained Earnings Accumulated Deficit | -4331350.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 488587.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 9959.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Shipping And Handling; | ||
| 0001641172-25-010300 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 264913.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Allergy Diagnostic Kit Sales; | ||
| 0001641172-25-010300 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 12320.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Training And Other Revenue; | ||
| 0001641172-25-010300 | 20241231 | Shares Outstanding | 1080092.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20241231 | Shares Outstanding | 2644424.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20231231 | Stockholders Equity | 108.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Issued For Services | 10.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Issued For Services | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-010300 | 20250331 | Accounts Receivable Net Current | 194978.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Assets Current | 420827.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Depreciation And Amortization | 18028.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -18525.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Income Taxes Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010300 | 20250331 | Income Tax Expense Benefit | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010300 | 20240331 | Increase Decrease In Accounts Payable | 85392.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Interest Expense | 67570.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Liabilities Current | 2407308.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Loans Payable Current | 391700.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Net Cash Provided By Used In Financing Activities | -46554.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-010300 | 20241231 | Preferred Stock Shares Issued | 1080092.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Preferred Stock Shares Issued | 2644424.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Preferred Stock Shares Outstanding | 2644424.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; | ||
| 0001641172-25-010300 | 20241231 | Preferred Stock Value | 264.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Preferred Stock Value | 108.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Research And Development Expense | 124033.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 237066.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Allergy Diagnostic Kit Sales; | ||
| 0001641172-25-010300 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | USD | 1 | us-gaap/2024 | Product Or Service= Clinical Study Revenue; | |||
| 0001641172-25-010300 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 9285.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Subscription Revenue; | ||
| 0001641172-25-010300 | 20240331 | Selling And Marketing Expense | 121946.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20231231 | Shares Outstanding | 1080092.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20240331 | Shares Outstanding | 1080092.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Shares Outstanding | 1080092.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20240331 | Stockholders Equity | -4001783.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010300 | 20250331 | Stockholders Equity | -4410959.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-010300 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-010300 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | 11952.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-010300 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 9877926.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Common Stock Shares Issued | 10806527.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Debt And Accrued Interest Converted To Shares Of Common Stock | 75000.0000 | USD | 1 | 0001641172-25-010300 | |||
| 0001641172-25-010300 | 20250331 | Earnings Per Share Basic | -0.0100 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Finite Lived Intangible Assets Net | 1342081.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | General And Administrative Expense | 89942.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Liabilities Current | 2259260.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Loans Payable Current | 438254.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Net Cash Provided By Used In Financing Activities | -41225.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-010300 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-010300 | 20240331 | Operating Income Loss | 13604.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20241231 | Preferred Stock Shares Authorized | 10000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Preferred Stock Shares Outstanding | 1080092.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001641172-25-010300 | 20250331 | Prepaid Expense And Other Assets Current | 40579.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20250331 | Proceeds From Related Party Debt | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-010300 | 20240331 | Research And Development Expense | 42638.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-010300 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 18370.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Subscription Revenue; | ||
| 0001641172-25-010300 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 9863.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Training And Other Revenue; | ||
| 0001641172-25-010300 | 20240331 | Stockholders Equity | 264.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Two Preferred Stock; Equity Components= Preferred Stock; | ||
| 0001641172-25-010300 | 20240331 | Stock Issued During Period Value Conversion Of Convertible Securities | USD | 1 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; | |||
| 0001641172-25-010300 | 20250331 | Stock Issued During Period Value Issued For Services | USD | 1 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; Equity Components= Preferred Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Stock Issued During Period Shares Issued For Services | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Issued for Services | Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. | |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Convertible Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Convertible Notes Payable, Current | Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Repayments Of Short Term Debt | us-gaap/2024 | 0 | 0 | monetary | D | C | Repayments of Short-Term Debt | The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Debt And Accrued Interest Converted To Shares Of Common Stock | 0001641172-25-010300 | 1 | 0 | monetary | D | C | Debt and accrued interest converted to shares of common stock | Debt and accrued interest converted to shares of common stock. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Interest Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Operating and Nonoperating | Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. |
| Selling And Marketing Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling and Marketing Expense | The aggregate total amount of expenses directly related to the marketing or selling of products or services. |
| Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | |
| Depreciation Depletion And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Stock Issued During Period Value Issued For Services | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Cost Of Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Other Current Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Other Current Liabilities | Amount of increase (decrease) in current liabilities classified as other. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Loans Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Loans Payable, Current | Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer. |
| Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Capitalized Computer Software Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Capitalized Computer Software, Net | The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date. |
| Finite Lived Intangible Assets Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Finite-Lived Intangible Assets, Net | Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Related Party Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
| Issuance Of Stock And Warrants For Services Or Claims | us-gaap/2024 | 0 | 0 | monetary | D | D | Issuance of Stock and Warrants for Services or Claims | Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. |
| Provision For Doubtful Accounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Accounts Receivable, Credit Loss Expense (Reversal) | Amount of expense (reversal of expense) for expected credit loss on accounts receivable. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-010300 | 2 | 9 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001641172-25-010300 | 2 | 10 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable, net | 0 |
| 0001641172-25-010300 | 2 | 11 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventory | 0 |
| 0001641172-25-010300 | 2 | 12 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaid expenses and other current assets | 0 |
| 0001641172-25-010300 | 2 | 13 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001641172-25-010300 | 2 | 15 | BS | 0 | H | Capitalized Computer Software Net | us-gaap/2024 | Capitalized software development costs, net | 0 |
| 0001641172-25-010300 | 2 | 16 | BS | 0 | H | Finite Lived Intangible Assets Net | us-gaap/2024 | Intangible assets, net | 0 |
| 0001641172-25-010300 | 2 | 17 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001641172-25-010300 | 2 | 20 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001641172-25-010300 | 2 | 21 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Other current liabilities | 0 |
| 0001641172-25-010300 | 2 | 22 | BS | 0 | H | Loans Payable Current | us-gaap/2024 | Loans payable | 0 |
| 0001641172-25-010300 | 2 | 23 | BS | 0 | H | Convertible Notes Payable Current | us-gaap/2024 | Convertible notes payable | 0 |
| 0001641172-25-010300 | 2 | 24 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001641172-25-010300 | 2 | 25 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001641172-25-010300 | 2 | 26 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 14) | 0 |
| 0001641172-25-010300 | 2 | 28 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock , value | 0 |
| 0001641172-25-010300 | 2 | 29 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, 900,000,000 shares authorized, $0.0001 par value; 11,281,527 and 10,806,527 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 0 |
| 0001641172-25-010300 | 2 | 30 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001641172-25-010300 | 2 | 31 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001641172-25-010300 | 2 | 32 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders deficit | 0 |
| 0001641172-25-010300 | 2 | 33 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders deficit | 0 |
| 0001641172-25-010300 | 3 | 7 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized | 0 |
| 0001641172-25-010300 | 3 | 8 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value | 0 |
| 0001641172-25-010300 | 3 | 9 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued | 0 |
| 0001641172-25-010300 | 3 | 10 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding | 0 |
| 0001641172-25-010300 | 3 | 11 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-010300 | 3 | 12 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-010300 | 3 | 13 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-010300 | 3 | 14 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-010300 | 4 | 1 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | Revenue | 0 |
| 0001641172-25-010300 | 4 | 2 | IS | 0 | H | Cost Of Revenue | us-gaap/2024 | Cost of revenue | 0 |
| 0001641172-25-010300 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
| 0001641172-25-010300 | 4 | 5 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001641172-25-010300 | 4 | 6 | IS | 0 | H | Selling And Marketing Expense | us-gaap/2024 | Sales and marketing | 0 |
| 0001641172-25-010300 | 4 | 7 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001641172-25-010300 | 4 | 8 | IS | 0 | H | Depreciation And Amortization | us-gaap/2024 | Amortization | 0 |
| 0001641172-25-010300 | 4 | 9 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total Operating Expenses | 0 |
| 0001641172-25-010300 | 4 | 10 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Net operating (loss) income | 0 |
| 0001641172-25-010300 | 4 | 12 | IS | 0 | H | Interest Expense | us-gaap/2024 | Interest expense | 1 |
| 0001641172-25-010300 | 4 | 13 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
| 0001641172-25-010300 | 4 | 14 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Provision on income taxes | 0 |
| 0001641172-25-010300 | 4 | 15 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-010300 | 4 | 16 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic net loss per share | 0 |
| 0001641172-25-010300 | 4 | 17 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted net loss per share | 0 |
| 0001641172-25-010300 | 4 | 18 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average shares outstanding basic | 0 |
| 0001641172-25-010300 | 4 | 19 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average shares outstanding diuted | 0 |
| 0001641172-25-010300 | 5 | 13 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-010300 | 5 | 14 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-010300 | 5 | 15 | EQ | 0 | H | Stock Issued During Period Value Issued For Services | us-gaap/2024 | Shares issued for services | 0 |
| 0001641172-25-010300 | 5 | 16 | EQ | 0 | H | Stock Issued During Period Shares Issued For Services | us-gaap/2024 | Shares issued for services, shares | 0 |
| 0001641172-25-010300 | 5 | 17 | EQ | 0 | H | Stock Issued During Period Value Conversion Of Convertible Securities | us-gaap/2024 | Conversion of notes payable | 0 |
| 0001641172-25-010300 | 5 | 18 | EQ | 0 | H | Stock Issued During Period Shares Conversion Of Convertible Securities | us-gaap/2024 | Conversion of notes payable, shares | 0 |
| 0001641172-25-010300 | 5 | 19 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-010300 | 5 | 20 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-010300 | 5 | 21 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-010300 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-010300 | 6 | 4 | CF | 0 | H | Provision For Doubtful Accounts | us-gaap/2024 | Allowance for doubtful accounts | 0 |
| 0001641172-25-010300 | 6 | 5 | CF | 0 | H | Depreciation Depletion And Amortization | us-gaap/2024 | Amortization | 0 |
| 0001641172-25-010300 | 6 | 6 | CF | 0 | H | Issuance Of Stock And Warrants For Services Or Claims | us-gaap/2024 | Shares issued for services | 0 |
| 0001641172-25-010300 | 6 | 8 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001641172-25-010300 | 6 | 9 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventory | 1 |
| 0001641172-25-010300 | 6 | 10 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other current assets | 1 |
| 0001641172-25-010300 | 6 | 11 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001641172-25-010300 | 6 | 12 | CF | 0 | H | Increase Decrease In Other Current Liabilities | us-gaap/2024 | Other current liabilities | 0 |
| 0001641172-25-010300 | 6 | 13 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Cash flows from operating activities | 0 |
| 0001641172-25-010300 | 6 | 15 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2024 | Proceeds from related-party borrowings | 0 |
| 0001641172-25-010300 | 6 | 16 | CF | 0 | H | Repayments Of Short Term Debt | us-gaap/2024 | Repayments of loan borrowings | 1 |
| 0001641172-25-010300 | 6 | 17 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Cash flows from financing activities | 0 |
| 0001641172-25-010300 | 6 | 18 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net change in cash | 0 |
| 0001641172-25-010300 | 6 | 19 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents beginning of year | 0 |
| 0001641172-25-010300 | 6 | 20 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | us-gaap/2024 | Cash and cash equivalents - end of period | 0 |
| 0001641172-25-010300 | 6 | 22 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001641172-25-010300 | 6 | 23 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for taxes | 0 |
| 0001641172-25-010300 | 6 | 25 | CF | 0 | H | Debt And Accrued Interest Converted To Shares Of Common Stock | 0001641172-25-010300 | Debt and accrued interest converted to shares of common stock | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |